BBGBloomberg·2hBusiness
score+0.50
Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal
Original
Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal
“Framing focuses on strategic growth and significant capital deployment for acquisition expansion.”